Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?
about
25-hydroxyvitamin D levels and the risk of mortality in the general populationVitamin D and cardiovascular disease: potential role in health disparitiesKlotho and phosphate are modulators of pathologic uremic cardiac remodeling.Treatment options of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease stages 3 and 4: an historic review.Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies.Vitamin d receptor activators and clinical outcomes in chronic kidney disease.The use of vitamin D analogues in chronic kidney diseases: possible mechanisms beyond bone and mineral metabolism.Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality.Vitamin D deficiency--prognostic marker or mortality risk factor in end stage renal disease patients with diabetes mellitus treated with hemodialysis--a prospective multicenter study1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyteEffect of paricalcitol and enalapril on renal inflammation/oxidative stress in atherosclerosis.Exploring metabolic dysfunction in chronic kidney disease.Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill.Omega-3 Fatty acids and vitamin d in cardiology.Secondary hyperparathyroidism in chronic kidney disease: focus on clinical consequences and vitamin D therapies.A bimodal association of vitamin D levels and vascular disease in children on dialysisExploration of association of 1,25-OH2D3 with augmentation index, a composite measure of arterial stiffness.Regression of vascular calcification in chronic kidney disease - feasible or fantasy? a review of the clinical evidence.Subclinical cardiovascular disease markers and vitamin D deficiency in non-dialysis chronic kidney disease patientsMechanisms for increased cardiovascular disease in chronic kidney dysfunction.Current advances in chronic kidney disease in children: growth, cardiovascular, and neurocognitive risk factors.Cardiovascular risk factors and prevention of cardiovascular disease in patients with chronic renal disease.The expanding spectrum of biological actions of vitamin D.Uraemic vasculopathy in children with chronic kidney disease: prevention or damage limitation?Vitamin D review.Cardiovascular risk assessment in children with chronic kidney disease.Pharmacologic targets and peritoneal membrane remodeling.Vitamin D Kinetics and Parathyroid Gland Function in Patients with Congenital Heart Disease.1,25-Dihydroxyvitamin D₃ suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation.Oral paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease.Vitamin D intake and cardiovascular mortality in the NHANES I epidemiological follow-up study cohort.Effect of alfacalcidol therapy on the survival of chronic hemodialysis patients.Serum 25-hydroxyvitamin D and parathyroid hormone levels in relation to blood pressure in a cross-sectional study in older Chinese men.Thyroid hormone replacement therapy for primary hypothyroidism leads to significant improvement of renal function in chronic kidney disease patients.Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis.Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.Efficacy and safety of nicotinamide in the management of hyperphosphatemia in pediatric patients on regular hemodialysis.Serum 25-hydroxyvitamin D, bone mineral density, and non-vertebral fracture risk in community-dwelling older men: results from Mr. Os, Hong Kong.The association of red blood cell counts with endothelin-1 in African and Caucasian women.
P2860
Q24650811-30AC1960-16AA-4030-A20C-B14922F43635Q26991916-EC0D643D-0384-43DA-AC00-FEBE9F653049Q27342649-CECE4D8C-96C3-4686-AF05-E30732EA8F88Q33610289-C3F82877-B3DC-445B-9710-26F85AD64015Q34491713-7EA7C21C-D5AF-411A-AC9F-660DC7078C9EQ34997739-BA664379-8A5D-4978-AB9F-C468D2959FE9Q35020986-D159CD25-4001-472F-8A77-6C7A09CAA0E1Q35573698-BB797386-2D5D-47A1-9179-921D9ED6C81AQ35593195-DE0C9628-6337-4F4D-842C-E8B18247DCF5Q35597780-6DDD977A-25CB-446D-B9F0-1F0C0631EB3EQ35839035-2D224F9A-DAE5-4353-826F-9C859854A978Q35996673-809D31D6-7E9E-48AE-BF1D-565EDE866AADQ36123347-A4ED5956-F0E4-43B1-9180-9A3D16980930Q36252398-F689D24D-56B2-4E40-9345-ACE0186226BCQ36546551-43FD2245-0E78-4B46-911A-A9DEFF2A90B2Q36567144-E805FEDB-5A0D-4BA5-B4C8-80D5B2BE46E6Q36677652-BFB7D703-6A2E-4404-A26F-6E0E671B1123Q36947355-D1D77409-3CFD-4664-898C-5C3459082F6FQ37219046-7678B33B-5816-49AE-8991-DDBFD2A6C804Q37243054-21975F81-F297-4CC0-84E9-AA5B70119ADCQ37289195-A0E865DE-A6DD-4952-9565-40D825E11AA1Q37395884-8508AC1B-64E8-46E2-86AE-2EAF94CC29D0Q37738896-94F7D45E-12E3-459C-924F-8289D0E0ED3BQ37762904-1F5CD9CD-DB66-47B3-BF1C-2C1B75684781Q37809763-9585731B-3BF7-48A4-B46F-066ECB04F30BQ37882860-BFF25BBC-E17C-40B5-8D1A-7BCD51F5B03FQ38052430-EA1594D1-D37D-4CF9-86D8-5431F7F3E5B4Q38187841-D6E51A04-6BC7-4B96-B0D1-774236D15758Q39634835-EDCCDCEC-89DE-4995-A3CA-99DB323FFB79Q41872361-311FC5DF-7780-453F-BBBA-9B70CEF73170Q42429155-C802E7B7-A272-4B0F-A3F2-57EE422C3E3DQ43683974-4F25BC2E-AD11-43A7-99DD-C3B9A50CE17BQ44984480-E1F52351-7D76-489C-BC40-09F2A1715EA3Q45164656-E6F259C2-88C6-499F-9E93-C5650F7E9DEBQ45779784-2D599A84-37F2-4FFA-9770-572A025189C3Q46146529-5A9DA121-7311-4A49-A2D1-8BB9B0D44456Q46519218-692C5034-13CB-4FC6-8F99-88DF009779ECQ46799066-996C88A0-8816-46C8-8E85-DDD199459A91Q47272905-E1124850-0690-46E0-AA74-165B32C3DF84Q50620507-EBE83412-ED19-45D2-B8CA-3369006A3A52
P2860
Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Vitamin D and its analogues: d ...... patients with kidney disease?
@ast
Vitamin D and its analogues: d ...... patients with kidney disease?
@en
type
label
Vitamin D and its analogues: d ...... patients with kidney disease?
@ast
Vitamin D and its analogues: d ...... patients with kidney disease?
@en
prefLabel
Vitamin D and its analogues: d ...... patients with kidney disease?
@ast
Vitamin D and its analogues: d ...... patients with kidney disease?
@en
P1433
P1476
Vitamin D and its analogues: d ...... patients with kidney disease?
@en
P2093
Adeera Levin
Yan Chun Li
P304
P356
10.1111/J.1523-1755.2005.00651.X
P407
P577
2005-11-01T00:00:00Z
P5875
P6179
1019873506